Next Article in Journal
Acceptability of Multiparticulate Dosing Using Sympfiny® Delivery System with Children (Age 1–12)
Next Article in Special Issue
Nanoparticles for Lymph Node-Directed Delivery
Previous Article in Journal
Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs
Previous Article in Special Issue
Nanomedicines Bearing an Alkylating Cytostatic Drug from the Group of 1,3,5-Triazine Derivatives: Development and Characterization
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(11), 2522; https://doi.org/10.3390/pharmaceutics14112522
Action Date Notes Link
article pdf uploaded. 19 November 2022 10:31 CET Version of Record https://www.mdpi.com/1999-4923/14/11/2522/pdf-vor
article xml file uploaded 22 November 2022 09:21 CET Original file -
article xml uploaded. 22 November 2022 09:21 CET Update https://www.mdpi.com/1999-4923/14/11/2522/xml
article pdf uploaded. 22 November 2022 09:21 CET Updated version of record https://www.mdpi.com/1999-4923/14/11/2522/pdf
article html file updated 22 November 2022 09:22 CET Original file -
article html file updated 3 March 2023 21:21 CET Update https://www.mdpi.com/1999-4923/14/11/2522/html
Back to TopTop